FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery
FDA批准摘要:Vorasidenib用于IDH突变型2级星形细胞瘤或少突胶质细胞瘤术后治疗
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1333
Barbato, Michael I; Barone, Amy K; Aungst, Stephanie L; Miller, Claudia P; Ananthula, Suryatheja; Bi, Youwei; Yang, Yuching; Li, Xiaoxue; Xiong, Ye; Fan, Jianghong; Dorff, Sarah E; Zhao, Hong; Zhou, Hua; Pradhan, Shan; Scepura, Barbara; Sinha, Arup K; Stephenson, Maritsa; Bhatnagar, Vishal; Saber, Haleh; Rahman, Nam Atiqur; Tang, Shenghui; Pazdur, Richard; Kluetz, Paul G; Larkins, Erin; Drezner, Nicole